Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 648 of 6351
-
Can we finally spot CTE before death? new study hopes to find out
Knowledge-focused By invitation onlyEach year, millions of people are exposed to repetitive head impacts (RHI) through contact sports. RHI can result in concussions and asymptomatic non-concussions to confer risk for Alzheimer's disease (AD) and related dementias (ADRD) including chronic traumatic encephalopathy (C…
Sponsor: Boston University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
New heart device could boost pumping power without surgery
Disease control Recruiting nowPatients with idiopathic dilated cardiomyopathy in heart failure (NYHA class III - IV) with a baseline left ventricular ejection fraction between ≥25% and ≤35%, and patients with non-ischemic cardiomyopathy in heart failure (NYHA class III-IV) with a baseline left ventricular eje…
Sponsor: Berlin Heals GmbH • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New hope for frail elderly lymphoma patients: Chemo-Free combo trial launches
Disease control Recruiting nowProspective, multicenter, single arm, phase II study, to evaluate the efficacy of the combination rituximab-golcadomide as a chemo free approach in a population of older patients with new diagnosis of DLBCL, defined as frail according to a sGA evaluation and not candidate for the…
Phase 2 • Sponsor: Fondazione Italiana Linfomi - ETS • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New drug shows promise for rare, severe childhood epilepsy
Disease control Recruiting nowThis is a multicenter, Phase 3, randomized, double-blind, placebo-controlled study designed to evaluate the efficacy and safety of clemizole HCL (EPX-100) as adjunctive therapy in children and adult participants with Lennox-Gastaut syndrome (LGS).
Phase 3 • Sponsor: Epygenix • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Can a dissolvable eye plug deliver targeted relief for dry eye?
Disease control CompletedThe goal of this clinical trial is to test if a new dissolvable tacrolimus plug placed in the tear duct is safe and to see how well it works for adults with moderate to severe dry eye. The main questions it aims to answer are: Is the dissolvable tacrolimus plug safe for the eyes…
Sponsor: Zhejiang Raytone Bioscience Co.,Ltd • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New drug could save infected joint implants, avoid major surgery
Disease control OngoingTRL1068 is expected to eliminate the pathogen-protecting biofilm in the prosthetic joint and surrounding tissue, thus making pathogens substantially more susceptible to established antibiotic treatment regimens. This Phase 2 study is designed to assess efficacy and safety of TRL1…
Phase 2 • Sponsor: Trellis Bioscience LLC • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New dosing strategy aims to tame stem cell transplant complications
Disease control Recruiting nowIn an effort to reduce graft versus host disease (GVHD) and enhance graft versus leukemia (GVL) effect post allogenic hematopoietic stem cell transplantation (AHSCT), recent research has focused on host immune cell depletion. Frame shifting anti-thymocyte globulin (ATG) backwards…
Phase 2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New hope for kids with tough cancer: drug may keep neuroblastoma at bay
Disease control OngoingEvaluate the impact of maintenance therapy with eflornithine on event-free survival and overall survival in high-risk neuroblastoma (NB) children after immunotherapy, and assess its safety.
Sponsor: Shanghai Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Weight-Loss drug tirzepatide takes on heart flutter in new trial
Disease control Recruiting nowThis is a single center randomized double blind controlled study of patients (BMI ≥ 27 kg/m2) with obesity and Atrial Fibrillation (AFIB) randomized to Tirzepatide vs. placebo. It is expected that the significant weight loss with Tirzepatide will result in improved control, manag…
Phase 2 • Sponsor: The Cleveland Clinic • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Heart procedure may fix leaky valves in AF patients, new trial aims to prove it
Disease control Recruiting nowAtrial fibrillation (AF) leads to atrial functional mitral regurgitation (MR) through mechanisms including mitral annular dilatation, systolic leaflet motion distance alteration, and contractility decrease. Compared with primary MR, atrial functional MR due to AF and other diseas…
Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Can ketamine quickly quiet suicidal thoughts? new brain scan study aims to find out
Symptom relief Recruiting nowThe goal of this clinical trial is to treat active suicidal ideation in individuals with Major Depressive Disorder (MDD) using ketamine and to understand suicidal ideation by examining biological mechanisms using magnetic resonance imaging (MRI), and psychological mechanisms thro…
Phase 2/3 • Sponsor: The Royal's Institute of Mental Health Research • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Could a wearable sensor improve pregnancy outcomes for women with type 2 diabetes?
Disease control Recruiting nowThe goal of this clinical trial is to learn if continuous glucose monitoring works better than self-monitoring of blood glucose (fingersticks) to treat type 2 diabetes in pregnancy. It will also learn about all risk factors (biologic, personal, social) for maternal and infant com…
Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Can a Four-Times-a-Year injection regrow hair in men?
Disease control Recruiting nowThis is a multi-centers, randomized, double-blind, parallel-group, Phase 3 Trial to evaluate the efficacy and safety of CKD-843 in Male patients with Androgenetic Alopecia
Phase 3 • Sponsor: Chong Kun Dang Pharmaceutical • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Experimental drug combo aims to extend cancer control in lung cancer
Disease control Recruiting nowThis phase I/II trial tests the safety, side effects, and best dose of iadademstat when given together with atezolizumab or durvalumab, and studies the effect of the combination in treating patients with small cell lung cancer that has spread outside of the lung in which it began…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New drug cocktail aims to save bladders in cancer fight
Disease control Recruiting nowPatients with MIBC will receive 3 cycles (C1-C3) of induction enfortumab vedotin plus pembrolizumab followed by restaging including MRI of the bladder, urine cytology, and cystoscopy with TURBT of any visible tumor and/or resection site plus random biopsies using a recommended te…
Phase 2 • Sponsor: Matthew Galsky • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Can a common muscle relaxant make radiation deadlier for rectal cancer?
Disease control Recruiting nowThis phase I trial studies the side effects and best dose of papaverine (PPV) when given together with radiation therapy (RT) and tests how well it works in treating patients with rectal cancer that has spread to nearby tissue or lymph nodes (locally advanced). PPV is an enzyme i…
Phase 1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Could ionized gas help fight breast cancer after surgery?
Disease control Recruiting nowThe goal of this clinical trial is to test the safety of the use of non-thermal plasma (NTP, an ionized gas) on the tumor bed after the removal of the tumor in breast cancer patients. The main questions it aims to answer are: * To determine the safe and tolerable dose of NTP in …
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New hope for heart lining pain: can CardiolRx keep flare-ups away?
Disease control Recruiting nowMulti-center, randomized, double-blind, placebo-controlled, phase-3 Trial. Patients with a history of recurrent pericarditis who are being treated with an IL-1 blocker for at least 12 months, scheduled to be discontinued, will be approached for potential trial participation. Dou…
Phase 3 • Sponsor: Cardiol Therapeutics Inc. • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Could a gut bacteria boost melanoma treatment? new trial aims to find out
Disease control Recruiting nowThis study is being done to answer the following question: Can the chance of melanoma growing or spreading be lowered by receiving a treatment called LND101 for Fecal Microbiota Transplant (FMT) in addition to the usual immunotherapy treatment called Immune Checkpoint Blockade (I…
Phase 2 • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New obesity pill shows promise in early trial
Disease control CompletedTo evaluate the efficacy of HRS9531 tablet compared with placebo in reducing body weight in obese subjects after 26 weeks of treatment.
Phase 2 • Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC